Current trends in medicinal treatment of endometriosis
https://doi.org/10.21518/2079-701X-2015-XX-28-33
Abstract
Endometriosis is one of the key challenges in modern gynecology. Despite significant advances in the present-day medicine, the pathogenesis of the disease is still not clearly defined, there is no consensus on diagnostic criteria; surgical techniques and energy-based methods of impact have been predominantly used, discussed and improved in the filed of treatment. Heterogeneity of clinical manifestations, disappointing consequences for the reproductive system, significant reduction in the quality of life make endometriosis a relevant medical and social problem with a huge demographic significance.
About the Authors
S. A. Orlova
Moscow Regional Research Institute of Obstetrics and Gynecology
Russian Federation
Russian Federation
V. E. Balan
Moscow Regional Research Institute of Obstetrics and Gynecology
Russian Federation
Russian Federation
E. A. Levkovich
Moscow Regional Research Institute of Obstetrics and Gynecology
Russian Federation
Russian Federation
References
1. Адамян Л.В. Эндометриозы: Руководство для врачей. Л.В. Адамян, В.И. Кулаков, Е.Н. Андреева. М.: Медицина, 2006.
2. Руководство по амбулаторно-поликлиниче-ской помощи в акушерстве и гинекологии. Под ред. В.И. Кулакова, В.Н. Прилепской, В.Е. Рад-зинского. М.: ГЭОТАР-Медиа, 2007. С. 683-714.
3. Эндометриоз: Диагностика, лечение и реабилитация. Клинические рекомендации по ведению больных. Под ред. Л.В. Адамян. 2013. С. 9-37.
4. В.Е. Радзинский, М.Б. Хамошина. Эндометриоз: лечить или не лечить, а если да, то чем? Фарматека, 2009, 9: 64-67.
5. Fagervold B et al. Acta Obstet Gyn Scan, 2009, 8: 914-919. Fourquet J et al. Fertil Steril, 2010, 7: 2424-2428.
6. Davis LJ et al. Cochrane Database Syst Rev, 2007, 3. CD001019. Vercellini P et al. Best Pract Res Clin Obstet Gynaecol, 2008, 22(2): 275-306.
7. Kappou D et al. Minerva Ginecol, 2010, 62: 415432.
8. Vercellini P et al. Hum Reprod Update, 2011, 17(2): 159-170.
9. Chapron Ch et al. Human Reproduction, 2011, 26(8): 2028-2035.
10. Harada T et al. Fertil Steril, 2008, 90(5): 15831588.
11. Barbieri RL. J Reprod Med, 1998, 43: 287-292.
12. GnRH Klipping C et al. J Clin Pharmacol, 2012, 52: 1704-1713. Barbieri RL. Am J Obster Gynecol, 1992, 166: 740-745.
13. Strowitzki T, Faustmann T, Gerlinger C, Seitz C. Dienogest in the treatment of endometriosis-associated pelvic pain a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol, 2010.
14. Schindler AE, Christensen B, Henkel A, Oettel M, Moore C. High-dose pilot study with the novel progestogen dienogest in patients with endometriosis. Gynecol. Endocrinol., 2006, 22: 9-17.
15. Momoeda M, Taketani Y. Randomized double-blind, multicentre, parallel-group dose-response study of dienogest in patients with endometriosis. J. Pharmacol. Ther., 2007, 35: 769-783.
16. Harada Т, Momoeda М, Taketani Y, Aso T. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis-a randomized, double-blind, multicenter, controlled trial. Fertility and Sterility, 2009, 3(91): 675-681.
Review
For citations:
Orlova SA, Balan VE, Levkovich EA. Current trends in medicinal treatment of endometriosis. Meditsinskiy sovet = Medical Council. 2015;(XX):28-33. (In Russ.) https://doi.org/10.21518/2079-701X-2015-XX-28-33
Views:
551
Email this article 